At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Sep 1998 Profile reviewed
- 02 May 1996 Investigation in Cancer in Japan (Unknown route)